Juvéderm Voluma® XC Receives FDA Approval

Posted February 13, 2017 in Injectables, Non-Surgical Procedures

Back to Index Arrow

The FDA approved JUVÉDERM VOLUMA® XC for correction of age-related volume loss in the mid-face in adults over the age of 21. JUVÉDERM VOLUMA® XC is a crosslinked hyaluronic acid (HA) filler of non-animal origin that includes lidocaine in the formulation.

The product is injected into the cheeks and nearby regions to temporarily restore volume and fullness to the areas. In the clinical study cited by the FDA, 86% of patients had an improvement in cheek fullness at six months with results lasting up to two years in a majority of subjects.

One early sign of aging can be volume loss in the cheeks from a combination of fat and bone absorption as well as gravitational descent. Juvederm Voluma is an excellent choice to restore volume in the upper cheek, and its exceptional longevity provides excellent “bang for the buck.”

The first step towards a new, beautiful you is to schedule a personal consultation.

Along with providing the highest level of care, no effort is spared to create an environment where each patient is nurtured and cared for as an individual. Use our form to contact Dr. O’Connell with questions about any of our aesthetic or plastic surgery procedures.

Call us Today (203) 454-0044